| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 84.49B | 88.97B | 78.40B | 80.35B | 55.52B | 36.16B |
| Gross Profit | 15.04B | 16.05B | 15.32B | 21.32B | 13.76B | 8.79B |
| EBITDA | 8.72B | 13.21B | 13.81B | 17.35B | 11.22B | 3.03B |
| Net Income | 2.53B | 3.73B | 4.95B | 7.50B | 3.69B | -3.16B |
Balance Sheet | ||||||
| Total Assets | 126.00B | 125.63B | 126.84B | 111.43B | 98.84B | 91.64B |
| Cash, Cash Equivalents and Short-Term Investments | 4.64B | 4.60B | 1.88B | 3.42B | 2.13B | 2.53B |
| Total Debt | 53.94B | 53.04B | 56.13B | 44.59B | 40.43B | 39.37B |
| Total Liabilities | 67.09B | 67.30B | 70.29B | 58.15B | 51.67B | 47.17B |
| Stockholders Equity | 58.91B | 58.33B | 56.55B | 53.15B | 47.03B | 44.33B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.91B | -11.23B | -1.16B | -637.00M | -6.61B |
| Operating Cash Flow | 0.00 | 19.28B | -3.13B | 5.29B | 9.79B | 1.40B |
| Investing Cash Flow | 0.00 | -11.63B | -8.01B | -6.76B | -10.43B | -8.39B |
| Financing Cash Flow | 0.00 | -4.93B | 9.61B | 2.73B | 206.00M | 6.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥182.56B | 17.88 | 5.78% | 1.49% | 0.82% | -1.72% | |
71 Outperform | ¥101.56B | 19.55 | ― | 1.38% | -3.56% | -30.17% | |
68 Neutral | ¥2.60T | 7.93 | 5.18% | 1.98% | 3.15% | -63.65% | |
68 Neutral | ¥85.23B | 7.97 | ― | 2.98% | 8.89% | 102.20% | |
66 Neutral | ¥670.21B | 3.88 | 3.12% | 2.83% | -0.64% | -65.65% | |
66 Neutral | ¥558.73B | 22.37 | 5.02% | 2.12% | -7.98% | -42.51% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |